查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1301150

美國氯胺酮診所市場規模、份額和趨勢分析報告：按療法、按治療、細分市場預測，2023-2030 年

U.S. Ketamine Clinics Market Size, Share & Trends Analysis Report By Treatment (Depression, Anxiety, PTSD), By Therapy (On-site Therapy, Online Therapy), And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

美國氯胺酮診所市場增長和趨勢

美國氯胺酮診所市場預計到 2030 年將達到 69 億美元。

從 2023 年到 2030 年，該市場預計將以 10.63% 的複合年增長率增長。 根據藥物濫用和心理健康服務管理局 (SAMHSA) 的數據，18 至 25 歲的年輕人中約有 13% 患有精神疾病或藥物濫用問題。 此外，四分之一的美國人患有精神疾病，三分之一的美國人患有藥物濫用障礙。 患有成癮和精神障礙的人數不斷增加，導致了這一增長。

COVID-19 大流行對在線氯胺酮治療診所產生了巨大影響。 在線診所面臨診所關閉、供應鏈中斷和擔心病毒傳播等問題。 因此，許多人避免去診所和醫院。 然而，大流行導緻美國的心理健康問題急劇上升，人們面臨著更大的壓力、焦慮和抑鬱。 日常生活的干擾、社會孤立以及經濟和就業壓力的增加導致精神健康障礙的增加。 根據美國心理健康 (MHA) 的數據，2020 年 1 月至 9 月在美國接受篩查的人中，35% 的人患有抑鬱症，20% 的人患有焦慮症。

美國氯胺酮診所行業的主要參與者正在實施各種戰略，包括併購、合作、業務擴張和推出新服務，以擴大其市場份額。 這些努力預計將有助於市場增長。 例如，2023 年 4 月，提供氯胺酮療法的 Mindbloom, Inc. 與基於技術的管理諮詢公司 SHIFT 合作。 作為此次合作的一部分，SHIFT 員工現在能夠以折扣價接受 Mindbloom 的家庭氯胺酮治療。 該計劃旨在為 SHIFT 員工提供寶貴的福利。

美國氯胺酮診所市場報告亮點

  • 從治療角度來看，由於患有嚴重抑鬱症的美國成年人數量不斷增加，抑鬱症細分市場將在 2022 年佔據最大的市場份額
  • 預計焦慮部分在預測期內增長最快。 焦慮症是美國最常見的精神疾病。 因此，對焦慮症的治療和支持的需求不斷增長，預計這將推動該行業的增長。
  • 按治療計算，現場治療細分市場在 2022 年佔據最大市場份額。 人們對氯胺酮治療精神疾病的接受度提高，導緻美國氯胺酮診所的擴張，進一步推動了該行業的增長。
  • 在線治療領域的增長對整個美國氯胺酮診所行業產生了重大影響。 遠程醫療和遠程醫療保健服務的興起極大地擴展了在線氯胺酮治療的可及性和便利性。

內容

第一章調查方法及範圍

  • 市場細分和範圍
    • 市場定義
  • 估計/預測時間表
  • 調查方法
  • 信息獲取
    • 購買的數據庫
    • GVR 內部數據庫
    • 二手信息和第三方觀點
    • 初步調查
  • 信息分析
    • 數據分析模型
  • 市場形成和數據可視化
  • 型號詳細信息
  • 輔助信息列表

第 2 章執行摘要

  • 市場概況
  • 片段快照
  • 競爭格局快照

第三章市場變量、趨勢和範圍

  • 市場體系展望
    • 母公司市場前景
    • 相關/補充市場前景
  • 市場趨勢和展望
  • 市場動態
    • 市場驅動因素分析
    • 市場製約因素分析
  • 商業環境分析
    • 杵分析
    • 波特五力分析
  • COVID-19 感染的影響分析

第 4 章治療業務分析

  • 氯胺酮診所市場：2022 年和 2030 年治療變化分析和市場份額
  • 抑鬱症
  • 焦慮
  • 創傷後應激障礙
  • 其他

第5章處理業務分析

  • 氯胺酮診所市場：2022 年和 2030 年治療變化分析和市場份額
  • 現場治療
  • 在線治療

第 6 章競爭格局

  • 公司分類
  • 戰略規劃
    • 擴展名
    • 獲取
    • 合作
    • 推出新產品
    • 其他
  • 公司簡介/列表
    • NY Ketamine Infusions
    • Field Trip Health and Wellness Ltd.
    • Ketamine Clinics Los Angeles
    • Klarity Clinic
    • Vitalitas Denver Ketamine Centers
    • Mindbloom, Inc
    • Nue Life Health
    • Better U, LLC
    • Innerwell
    • Klarisana

第 7 章建議/主要市場洞察

Product Code: GVR-4-68040-092-1

U.S. Ketamine Clinics Market Growth & Trends

The U.S. ketamine clinics market size is expected to reach USD 6.9 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 10.63% from 2023 to 2030. The market is experiencing significant growth, driven by factors such as increasing mental health awareness, the ongoing opioid crisis, and expanding number of ketamine clinics across the U.S. According to the Substance Abuse and Mental Health Services Administration (SAMHSA), about 13% of young adults aged 18 to 25 have mental or substance use problems. Additionally, 1 in 4 Americans have a mental illness, and 1 out of 3 have a substance use disorder. The increasing number of people with addictions and mental health disorders is contributing to the growth.

The COVID-19 pandemic had a significant impact on online ketamine therapy clinics. While onsite providers faced challenges such as lockdowns, disruptions in the supply chain, and people's fear of contracting the virus. Consequently, many individuals avoided visiting clinics or hospitals. However, the pandemic led to a surge in mental health issues in the U.S. as people faced increased stress, anxiety, and depression. Disruptions in daily routines, social isolation, and increased stress related to finances and employment contributed to a rise in mental health disorders. According to Mental Health America (MHA), 35% of the people screened in the U.S. from January to September 2020 reported having depression, while 20% reported experiencing anxiety.

Key players in the U.S. ketamine clinics industry are implementing various strategies such as mergers & acquisitions, partnerships, expansions, and launching new services to expand their market presence. These efforts are expected to contribute to the market's growth. For instance, in April 2023, Mindbloom, Inc., a ketamine therapy provider, partnered with SHIFT, a tech-based management consulting company. As part of this partnership, SHIFT employees will now have the opportunity to receive at-home ketamine therapy from Mindbloom at a reduced cost compared to the regular price. This initiative aims to provide a valuable benefit to SHIFT employees.

U.S. Ketamine Clinics Market Report Highlights

  • Based on the treatment, the depression segment held the largest market share in 2022 owing to the growing number of American adults burdened with severe major depression
  • The anxiety segment is anticipated to witness the fastest growth over the forecast period. Anxiety disorders are the most widespread mental illness in the U.S. As a result, there is an increased need for treatment and support for anxiety disorders, which is expected to drive the segment's growth
  • Based on the therapy, the on-site therapy segment held the largest market share in 2022. Growing acceptance of ketamine therapy for mental health disorder is led to an expansion of ketamine clinics in the U.S., further driving the segment growth
  • The growth of the online therapy segment significantly impacted the overall U.S. ketamine clinics industry. With the rise of telehealth and remote healthcare services, the accessibility and convenience of online ketamine therapy have expanded significantly

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Market Definitions
  • 1.2. Estimates and Forecast Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources & Third-Party Perspectives
    • 1.4.4. Primary Research
  • 1.5. Information Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Data Visualization
  • 1.7. Model Details
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Business Environment Analysis
    • 3.4.1. PESTLE Analysis
    • 3.4.2. Porter's Five Forces Analysis
  • 3.5. COVID-19 Impact Analysis

Chapter 4. Treatment Business Analysis

  • 4.1. Ketamine Clinics Market: Treatment Movement Analysis & Market Share, 2022 & 2030
  • 4.2. Depression
    • 4.2.1. U.S. Depression Market, 2018 - 2030 (USD Million)
  • 4.3. Anxiety
    • 4.3.1. U.S. Anxiety Market, 2018 - 2030 (USD Million)
  • 4.4. PTSD
    • 4.4.1. U.S. PTSD Market, 2018 - 2030 (USD Million)
  • 4.5. Others
    • 4.5.1. U.S. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Therapy Business Analysis

  • 5.1. Ketamine Clinics Market: Therapy Movement Analysis & Market Share, 2022 & 2030
  • 5.2. On-Site Therapy
    • 5.2.1. U.S. On-Site Therapy Market, 2018 - 2030 (USD Million)
  • 5.3. Online Therapy
    • 5.3.1. U.S. Online Therapy Market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company Categorization
  • 6.2. Strategy Mapping
    • 6.2.1. Expansion
    • 6.2.2. Acquisition
    • 6.2.3. Collaborations
    • 6.2.4. New Product Launches
    • 6.2.5. Others
  • 6.3. Company Profiles/Listing
    • 6.3.1. NY Ketamine Infusions
      • 6.3.1.1. Overview
      • 6.3.1.2. Financial Performance
      • 6.3.1.3. Product Benchmarking
      • 6.3.1.4. Strategic Initiatives
    • 6.3.2. Field Trip Health and Wellness Ltd.
      • 6.3.2.1. Overview
      • 6.3.2.2. Financial Performance
      • 6.3.2.3. Product Benchmarking
      • 6.3.2.4. Strategic Initiatives
    • 6.3.3. Ketamine Clinics Los Angeles
      • 6.3.3.1. Overview
      • 6.3.3.2. Financial Performance
      • 6.3.3.3. Product Benchmarking
      • 6.3.3.4. Strategic Initiatives
    • 6.3.4. Klarity Clinic
      • 6.3.4.1. Overview
      • 6.3.4.2. Financial Performance
      • 6.3.4.3. Product Benchmarking
      • 6.3.4.4. Strategic Initiatives
    • 6.3.5. Vitalitas Denver Ketamine Centers
      • 6.3.5.1. Overview
      • 6.3.5.2. Financial Performance
      • 6.3.5.3. Product Benchmarking
      • 6.3.5.4. Strategic Initiatives
    • 6.3.6. Mindbloom, Inc
      • 6.3.6.1. Overview
      • 6.3.6.2. Financial Performance
      • 6.3.6.3. Product Benchmarking
      • 6.3.6.4. Strategic Initiatives
    • 6.3.7. Nue Life Health
      • 6.3.7.1. Overview
      • 6.3.7.2. Financial Performance
      • 6.3.7.3. Product Benchmarking
      • 6.3.7.4. Strategic Initiatives
    • 6.3.8. Better U, LLC
      • 6.3.8.1. Overview
      • 6.3.8.2. Financial Performance
      • 6.3.8.3. Product Benchmarking
      • 6.3.8.4. Strategic Initiatives
    • 6.3.9. Innerwell
      • 6.3.9.1. Overview
      • 6.3.9.2. Financial Performance
      • 6.3.9.3. Product Benchmarking
      • 6.3.9.4. Strategic Initiatives
    • 6.3.10. Klarisana
      • 6.3.10.1. Overview
      • 6.3.10.2. Financial Performance
      • 6.3.10.3. Product Benchmarking
      • 6.3.10.4. Strategic Initiatives

Chapter 7. Recommendations/Key Market Insights

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. U.S. ketamine clinics market, by treatment, 2018 - 2030 (USD Million)
  • Table 4. U.S. ketamine clinics market, by therapy, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 US ketamine clinics market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Segment snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 Market trends & outlook
  • Fig. 12 Market driver relevance analysis (current & future impact)
  • Fig. 13 Market restraint relevance analysis (current & future impact)
  • Fig. 14 PESTLE analysis
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 U.S. ketamine clinics market: Treatment outlook and key takeaways
  • Fig. 17 U.S. ketamine clinics market: Treatment movement analysis
  • Fig. 18 Depression market revenue, 2018 - 2030 (USD Million)
  • Fig. 19 Anxiety market revenue, 2018 - 2030 (USD Million)
  • Fig. 20 PTSD market revenue, 2018 - 2030 (USD Million)
  • Fig. 21 U.S. ketamine clinics market: Therapy outlook and key takeaways
  • Fig. 22 U.S. ketamine clinics market: Therapy movement analysis
  • Fig. 23 On-site therapy market revenue, 2018 - 2030 (USD Million)
  • Fig. 24 Online therapy market revenue, 2018 - 2030 (USD Million)
  • Fig. 25 Company categorization
  • Fig. 26 Strategy mapping
  • Fig. 27 Company market position analysis